Skip to main content

Table 1 Baseline and clinical characteristics

From: Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke

  Controls (n = 61) Patients  
6 h (n = 80) 48 h (n = 85)
Demographic characteristics
 Age ≥ 50 years, n (%) 52 (85) 75 (94) 73 (86)
 Gender, (M/F) 26/35 33/47 49/36
 Race caucasian, n (%) 61 (100) 80 (100) 82 (96)
Risk factors, n (%)
 Hypertension 15 (24) 60 (75)***, # 60 (70)**
 Diabetes 3 (5) 11 (14) 29 (34)***, ##
 Dyslipidemia 12 (20) 43 (54)*** 39 (46)
 Cardiovascular diseases 2 (3) 24 (30)*** 19 (22)
 Atrial fibrillation 2 (3) 30 (37)*** 15 (18)*
 Smoking history 22 (37) 21 (26) 44 (57)
 Recent Infections 2 (3) 1 (1)
 CRP ≥ 3 mg/l 5 (6) 16 (19)
Clinical characteristics
 TOAST classification, n (%)    
  Cardioembolism   24 (30) 23 (27)
  Atherosclerosis   21 (26) 33 (39)
  Small vessel occlusion   11 (14) 6 (7)
  Undetermined etiology   24 (30) 22 (25)
  Other determined etiology   2 (2)
 NIHSS, median (IQR)   5 (2–11) 5 (2–11)
  Severe (>14), n (%)   12 (16) 14 (17)
 3-month mRS, median (IQR)   2 (1–4) 1 (0–3)
  mRS (>2), n (%)   33 (41) 36 (42)
  Mortality   10 (12) 2 (3)
  1. Categorical variables are presented as number of patients with/without percentages in parentheses; continuous variables as median with interquartile range (IQR). Age was dichotomized using 50 years as cut-off (based on the minimum quartile in control group)
  2. TOAST Trial of Org 10172 in Acute Stroke Treatment, NIHSS National Institutes of Health Stroke Scale, 3-month mRS 3-month modified Rankin Scale, CRP C-reactive protein
  3. *<0.05, **<0.01, ***<0.001, vs control group by univariate and #<0.05, ##<0.01 by multivariate logistic regression analysis